Johns Hopkins to Evaluate Rosetta Genomics' Lung miRNA Cancer Diagnostic | GenomeWeb
NEW YORK (GenomeWeb News) - Rosetta Genomics said today that it is partnering with Johns Hopkins University School of Medicine on a clinical assessment study of its microRNA-based miRview Squamous diagnostic, which is designed to differentiate squamous from non-squamous non-small cell lung cancer.

The study will compare miRview squamous with available immunohistochemistry methods.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.